TokenPost·
vTv Therapeutics Posts a $0.94 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate
Cash and cash equivalents were $77.2 million on Sept. 30, 2026, compared with $88.9 million on Dec. 31, 2025.
More news
- TokenPostAI Study Finds More One-Off Training Examples Raise Exact Science Matches
- TokenPostTemporal CEO Says Solana Needs a Stronger Derivatives Market
- TokenPostAmerican Healthcare REIT Posts $742.1M Q3 Revenue, $0.58 FFO Per Share
- BitcoinistAI IPO Dilution Could Fuel Crypto’s Next Rally, Analyst Warns
- TokenPostHyperliquid Strategies Unit Seeks U.S. Futures Commission Merchant Status
- TokenPostIndia's CERT-In Warns Crypto Firms of Active CRAFTY FALCON Attacks